Virus, liver and autoimmunity

Digestive and Liver Disease

Volumn 32, Issue 5, 2000, Pages 440-446

  Bogdanos, D P ^a   Mieli Vergani, G ^b   Vergani, D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Autoimmunity; Cross reactivity; Hepatitis; Molecular mimicry; Virus

Indexed keywords

CYTOCHROME P450 ISOENZYME; MUSCLE ANTIGEN; MYELIN BASIC PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN RECOGNITION; AUTOIMMUNITY; CONTROLLED STUDY; CROSS REACTION; HEPATITIS B; HEPATITIS C; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; LIVER DISEASE; MOLECULAR MIMICRY; NONHUMAN; RABBIT; REVIEW; SEQUENCE HOMOLOGY; TISSUE INJURY; VIRUS MORPHOLOGY;

ANIMALS; AUTOIMMUNITY; CROSS REACTIONS; HEPATITIS B; HEPATITIS C; HUMANS; LIVER; MOLECULAR MIMICRY;

EID: 0033861578     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(00)80266-2     Document Type: Review

References (66)

1. Immunological liver diseases in children
2. The concept of autoimmune liver diseases
3. Cytotoxic T cells and viral hepatitis
4. Hepatitis B infection: Pathogenesis and management
5. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
6. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase
7. Type II autoimmune hepatitis. What is the role of the hepatitis C virus?
8. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection
9. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
10. Autoantibody prevalence in chronic hepatitis B virus infection: Effect in interferon alpha
11. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection
12. Serum autoantibodies in chronic hepatitis C: Comparisson with autoimmune hepatitis and impact on the disease profile
13. Non-organ specific autoantibodies associated with chronic C virus hepatitis
14. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
15. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: A nested case-control study of the Dionysos cohort
16. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study
17. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis
18. Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of American
19. Non-organ specific autoantibodies in children with chronic hepatitis C
20. NOSA in HCV infection: Markers or makers of disease?
21. Hepatitis C virus infection, alpha interferon theraphy and thyroid dysfunstion
22. Side effects of alpha interferon in chronic hepatitis C
23. Virus-induced autoimmune disease
24. Epidemiologic evidence for multiple sclerosis as an infection
25. The epidemiology of insulin dependent diabetes with particular reference to the relationships of virus infection to its etiolgy
26. The geographic distribution of multiple sclerosis: A review
27. The role of genetic factors in the development of insulin-dependent diabetes mellitus
28. A population-based study of multiple sclerosis in twins
29. Discordance for ankylosing spondylitis in monozygotic twins
30. Review of the contribution of twin studies in the search for non-genetic causes of multiple sclerosis
31. Molecular mimicry and autoimmune disease
32. Rubella infection and diabetes mellitus
33. Molecular mimicry and immune-mediated disease
34. Molecular mimicry in the MHC: Hidden clues to autoimmunity?
35. Molecular mimicry and T cell-mediated autoimmune disease
36. Identification of high potency microbial and self ligands for a human autoreactive class II restricted T cell clone
37. Molecular mimicry between non-self, modified self and self in autoimmunity
38. Molecular mimicry: Can epitope mimicry induce autoimune diesease?
39. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides actives human T cell clones specific for myelin basic protein
40. Molecular mimicry and autoimmunity
41. Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction
42. Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues
43. Atigenic mimicry between measles virus and human T lymphocytes
44. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: A paradigm for autoimmune disease
45. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
46. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats
47. Molecular mimicry: Uveitis induced in Macaca fascicularis by microbial protein having sequence homology with retinal S-antigen
48. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis
49. Microsomal antibodies in active chronic hepatitis and other disorders
50. LKM antibody: Getting in some target practice
51. Type II autoimmune hepatitis: The conundrum of cytochrome P450IID6
52. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane
53. Generation of Liver/Kidney Microsomal-1 antibody in HCV infection: The role of molecular mimicry
54. New viral triggers of autoreactivity to cytochrome P4502D6, the target of liver kidney microsomal autoantibody
55. Multiple overlapping homologies between two rheumatoid antigens and immunosuppressive viruses
56. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition
57. Hepatitis C virus and autoimmunity
58. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: Implication for an autoimmune process
59. Anti-GOR and hepatitis C virus in autoimmune liver diseases
60. An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen
61. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein
62. Anti-HCV, anti-GOR, and autoimmunity
63. Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease